The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of lurbinectedin (LUR) with irinotecan (IRI) in patients (Pts) with relapsed small cell lung cancer (SCLC): Results from a phase 2 expansion cohort.
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Stab Therapeutics
Stock and Other Ownership Interests - Altum Sequencing; Stab therapeutics
Honoraria - Amgen; AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Janssen; Lilly; Medscape; Merck Serono; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Regeneron; Roche/Genentech; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; AstraZeneca; Bayer; BMS; GlaxoSmithKline; Janssen; Lilly; Merck; Mirati Therapeutics; MSD; Novartis; Pfizer; Pharmamar; Regeneron; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); MSD (Inst); Pfizer (Inst); PharmaMar (Inst)
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Alejandro Falcon Gonzalez
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche/Genentech; Steve
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Grunenthal; Lilly; Novartis; Pfizer; Roche/Genentech; Seagen
 
Alejandro Navarro
Consulting or Advisory Role - Adium Pharma; Amgen; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Eczacibasi; Pfizer; Takeda
Speakers' Bureau - AstraZeneca Spain; Roche
Expert Testimony - Hengenix; Medsir; Oryzon Genomics
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Amparo Sanchez-Gastaldo
No Relationships to Disclose
 
Gregory Michael Cote
Honoraria - BioAtla; Gilead Sciences
Consulting or Advisory Role - C4 Therapeutics; Daiichi Sankyo/UCB Japan; Ikena Oncology; Sonata
Research Funding - Bavarian Nordic; Bayer (Inst); BioAtla (Inst); C4 Therapeutics (Inst); Eisai (Inst); Epizyme (Inst); Foghorn Therapeutics (Inst); Ikena Oncology (Inst); Jazz Pharmaceuticals (Inst); Kronos Bio (Inst); Macrogenics (Inst); Merck KGaA (Inst); PharmaMar (Inst); Pyxis (Inst); Rain Therapeutics (Inst); Repare Therapeutics (Inst); Servier (Inst); Springworks Therapeutics (Inst); Sumitomo Dainippon Pharma Oncology (Inst)
 
Bruno Bockorny
Honoraria - BiolineRx; Enlivex Therapeutics Ltd
Consulting or Advisory Role - Blueprint Medicines
Research Funding - Agenus (Inst); Nanoview Diagnostics
Travel, Accommodations, Expenses - Agenus; ERYTECH Pharma
 
Javier Molina-Cerrillo
Consulting or Advisory Role - Pfizer, Ipsen, Bristol-Myers Squibb, Jansen, Eisai, Sanofi, Advanced Accelerator Applications
Speakers' Bureau - Bristol-Myers Squibb, Ipsen, Pfizer
Research Funding - Pfizer, Ipsen
Travel, Accommodations, Expenses - Ipsen
 
Angel Artal
No Relationships to Disclose
 
Javier Baena
Honoraria - AstraZeneca Spain; AstraZeneca Spain; Bristol-Myers Squibb/Pfizer
Consulting or Advisory Role - Access Oncology; AstraZeneca Spain; Roche; Roche
Expert Testimony - Roche
Travel, Accommodations, Expenses - Janssen Oncology; MSD; MSD; Roche; Roche
 
Ana Gil
Consulting or Advisory Role - Astrazeneca
Speakers' Bureau - Pfizer Daichii Novartis
 
Santiago Ponce Aix
Speakers' Bureau - Pfizer, Astra Zeneca
 
Helena Bote de Cabo
Travel, Accommodations, Expenses - Roche, Takeda
 
Sara Martinez
Employment - PharmaMar
 
Julia Martinez Martinez
No Relationships to Disclose
 
Jose Antonio Lopez-Vilariño
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Carmen Maria Kahatt
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Ali Hassan Zeaiter
Employment - PharmaMar
Leadership - PharmaMar
Stock and Other Ownership Interests - PharmaMar; SERVIER
Honoraria - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Javier Gomez
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
Patents, Royalties, Other Intellectual Property - Lurbinectedin. PharmaMar
 
Jon Zugazagoitia
Honoraria - AstraZeneca Spain; Bristol-Myers Squibb/Celgene; Guardant Health; NanoString Technologies; Pfizer; Roche/Genentech; Sanofi/Regeneron
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; Novartis; Novartis; Pfizer; Sanofi/Regeneron
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; MSD Oncology; NanoString Technologies; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/Celgene; Roche/Genentech; Sanofi